Clinical Pharmacology Details


SUCRALFATE


View Drug Forms

Indications & Dose:

Benign gastric ulceration


 Benign duodenal ulceration



Child 15–17 years: 2 g twice daily, dose to be taken on rising and at bedtime, alternatively 1 g 4 times a day for 4–6 weeks, or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime;maximum 8 g per day


Adult: 2 g twice daily, dose to be taken on rising and atbedtime, alternatively 1 g 4 times a day for 4–6 weeks,


or in resistant cases up to 12 weeks, dose to be taken 1 hour before meals and at bedtime; maximum 8 g per day


Chronic gastritis



Adult: 2 g twice daily, dose to be taken on rising and atbedtime, alternatively 1 g 4 times a day for 4–6 weeks or in resistant cases up to 12 weeks, dose to be taken1 hour before meals and at bedtime; maximum 8 g per day


Prophylaxis of stress ulceration in child under intensive care 



Child 15–17 years: 1 g 6 times a day; maximum 8 g per day continued


Prophylaxis of stress ulceration



Adult: 1 g 6 times a day; maximum 8 g per day.


NOTE; Tablets may be dispersed in 10-15ml of water; antacids should not be taken half an hour before or after a dose.


Children: Doses of 40-80mg/kg/day divided every 6 hours


 

Contraindications:

Renal impairment

Side Effects:

CNS: Dizziness, drowsiness, headache, vertigo


Eye/ENT: Laryngospasm


GI: Constipation, diarrhea, dry mouth, gastric pain, indigestion, nausea, vomiting


SKIN: Pruritus, rash. urticaria

Cautions:

In pregnancy & breast-feeding

Precautions:

Renal failure, dialysis (small amounts aluminum absorbed with sucralfate)

Interaction:

Drugs


Ketoconazole: Reduces plasma levels of antifungal


Phenytoin: Modest reduction in GI absorption of phenytoln


Quinolones: Reduced antibiotic levels


Warfarin: Isolated cases of reduced hypoprothrombinemic response to warfarin

Warnings:

Adverse Effects:

Lactations:

Special Precautions:

Counselling:

Side Effects Or Adverse Reactions:

Patient And Carer Advice: